Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
162M
-
Number of holders
-
247
-
Total 13F shares, excl. options
-
165M
-
Shares change
-
-1.07M
-
Total reported value, excl. options
-
$1.75B
-
Value change
-
-$10M
-
Put/Call ratio
-
0.07
-
Number of buys
-
141
-
Number of sells
-
-105
-
Price
-
$10.64
Significant Holders of IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) as of Q2 2023
281 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - Class A Common Stock as of Q2 2023.
IRONWOOD PHARMACEUTICALS INC - Class A Common Stock (IRWD) has 247 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 165M shares
.
Largest 10 shareholders include BlackRock Inc. (25.8M shares), Sarissa Capital Management LP (16.4M shares), VANGUARD GROUP INC (14.8M shares), STATE STREET CORP (11M shares), LSV ASSET MANAGEMENT (7.67M shares), CREDIT SUISSE AG/ (5.8M shares), DIMENSIONAL FUND ADVISORS LP (5.61M shares), RENAISSANCE TECHNOLOGIES LLC (5.32M shares), BROWN CAPITAL MANAGEMENT LLC (3.75M shares), and VICTORY CAPITAL MANAGEMENT INC (3.74M shares).
This table shows the top 247 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.